307 related articles for article (PubMed ID: 9164192)
1. Common and variant gene fusions predict distinct clinical phenotypes in rhabdomyosarcoma.
Kelly KM; Womer RB; Sorensen PH; Xiong QB; Barr FG
J Clin Oncol; 1997 May; 15(5):1831-6. PubMed ID: 9164192
[TBL] [Abstract][Full Text] [Related]
2. Detection of the PAX3-FKHR fusion gene in paediatric rhabdomyosarcoma: a reproducible predictor of outcome?
Anderson J; Gordon T; McManus A; Mapp T; Gould S; Kelsey A; McDowell H; Pinkerton R; Shipley J; Pritchard-Jones K;
Br J Cancer; 2001 Sep; 85(6):831-5. PubMed ID: 11556833
[TBL] [Abstract][Full Text] [Related]
3. PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the children's oncology group.
Sorensen PH; Lynch JC; Qualman SJ; Tirabosco R; Lim JF; Maurer HM; Bridge JA; Crist WM; Triche TJ; Barr FG
J Clin Oncol; 2002 Jun; 20(11):2672-9. PubMed ID: 12039929
[TBL] [Abstract][Full Text] [Related]
4. Genetic heterogeneity in the alveolar rhabdomyosarcoma subset without typical gene fusions.
Barr FG; Qualman SJ; Macris MH; Melnyk N; Lawlor ER; Strzelecki DM; Triche TJ; Bridge JA; Sorensen PH
Cancer Res; 2002 Aug; 62(16):4704-10. PubMed ID: 12183429
[TBL] [Abstract][Full Text] [Related]
5. Detection of PAX3-FKHR and PAX7-FKHR fusion transcripts in rhabdomyosarcoma by reverse transcriptase-polymerase chain reaction using paraffin-embedded tissue.
Chen BF; Chen ML; Liang DC; Huang YW; Liu HC; Chen SH
Zhonghua Yi Xue Za Zhi (Taipei); 1999 Feb; 62(2):86-91. PubMed ID: 10063718
[TBL] [Abstract][Full Text] [Related]
6. Minimal disease detection in patients with alveolar rhabdomyosarcoma using a reverse transcriptase-polymerase chain reaction method.
Kelly KM; Womer RB; Barr FG
Cancer; 1996 Sep; 78(6):1320-7. PubMed ID: 8826957
[TBL] [Abstract][Full Text] [Related]
7. Proliferative and apoptotic differences between alveolar rhabdomyosarcoma subtypes: a comparative study of tumors containing PAX3-FKHR or PAX7-FKHR gene fusions.
Collins MH; Zhao H; Womer RB; Barr FG
Med Pediatr Oncol; 2001 Aug; 37(2):83-9. PubMed ID: 11496344
[TBL] [Abstract][Full Text] [Related]
8. In vivo amplification of the PAX3-FKHR and PAX7-FKHR fusion genes in alveolar rhabdomyosarcoma.
Barr FG; Nauta LE; Davis RJ; Schäfer BW; Nycum LM; Biegel JA
Hum Mol Genet; 1996 Jan; 5(1):15-21. PubMed ID: 8789435
[TBL] [Abstract][Full Text] [Related]
9. Fusion genes resulting from alternative chromosomal translocations are overexpressed by gene-specific mechanisms in alveolar rhabdomyosarcoma.
Davis RJ; Barr FG
Proc Natl Acad Sci U S A; 1997 Jul; 94(15):8047-51. PubMed ID: 9223312
[TBL] [Abstract][Full Text] [Related]
10. Gene fusions involving PAX and FOX family members in alveolar rhabdomyosarcoma.
Barr FG
Oncogene; 2001 Sep; 20(40):5736-46. PubMed ID: 11607823
[TBL] [Abstract][Full Text] [Related]
11. Detection and clinical significance of bone marrow involvement in patients with rhabdomyosarcoma.
Krsková L; Mrhalová M; Hilská I; Sumerauer D; Drahokoupilová E; Múdry P; Kodet R
Virchows Arch; 2010 May; 456(5):463-72. PubMed ID: 20405298
[TBL] [Abstract][Full Text] [Related]
12. [Detection of PAX3/PAX7-FKHR fusion transcript in rhabdomyosarcoma by one-step RT-PCR].
Chang B; Yin BM; Li F; Li XX; Lu TC; Hu WH; Jiang JF; Shi DR
Zhonghua Yi Xue Za Zhi; 2003 Aug; 83(15):1336-8. PubMed ID: 12930690
[TBL] [Abstract][Full Text] [Related]
13. PAX3 and PAX7 exhibit conserved cis-acting transcription repression domains and utilize a common gain of function mechanism in alveolar rhabdomyosarcoma.
Bennicelli JL; Advani S; Schäfer BW; Barr FG
Oncogene; 1999 Jul; 18(30):4348-56. PubMed ID: 10439042
[TBL] [Abstract][Full Text] [Related]
14. Novel formation and amplification of the PAX7-FKHR fusion gene in a case of alveolar rhabdomyosarcoma.
Weber-Hall S; McManus A; Anderson J; Nojima T; Abe S; Pritchard-Jones K; Shipley J
Genes Chromosomes Cancer; 1996 Sep; 17(1):7-13. PubMed ID: 8889501
[TBL] [Abstract][Full Text] [Related]
15. Pax3-fkhr and pax7-fkhr fusion genes impact outcome of alveolar rhabdomyosarcoma in children.
Kazanowska B; Reich A; Stegmaier S; Békássy AN; Leuschner I; Chybicka A; Koscielniak E
Fetal Pediatr Pathol; 2007; 26(1):17-31. PubMed ID: 17613043
[TBL] [Abstract][Full Text] [Related]
16. Co-expression of alternatively spliced forms of PAX3, PAX7, PAX3-FKHR and PAX7-FKHR with distinct DNA binding and transactivation properties in rhabdomyosarcoma.
Du S; Lawrence EJ; Strzelecki D; Rajput P; Xia SJ; Gottesman DM; Barr FG
Int J Cancer; 2005 May; 115(1):85-92. PubMed ID: 15688409
[TBL] [Abstract][Full Text] [Related]
17. Structural analysis of PAX7 rearrangements in alveolar rhabdomyosarcoma.
Fitzgerald JC; Scherr AM; Barr FG
Cancer Genet Cytogenet; 2000 Feb; 117(1):37-40. PubMed ID: 10700864
[TBL] [Abstract][Full Text] [Related]
18. Fusion of PAX7 to FKHR by the variant t(1;13)(p36;q14) translocation in alveolar rhabdomyosarcoma.
Davis RJ; D'Cruz CM; Lovell MA; Biegel JA; Barr FG
Cancer Res; 1994 Jun; 54(11):2869-72. PubMed ID: 8187070
[TBL] [Abstract][Full Text] [Related]
19. PAX7 expression in embryonal rhabdomyosarcoma suggests an origin in muscle satellite cells.
Tiffin N; Williams RD; Shipley J; Pritchard-Jones K
Br J Cancer; 2003 Jul; 89(2):327-32. PubMed ID: 12865925
[TBL] [Abstract][Full Text] [Related]
20. Global gene expression profiling of PAX-FKHR fusion-positive alveolar and PAX-FKHR fusion-negative embryonal rhabdomyosarcomas.
Laé M; Ahn EH; Mercado GE; Chuai S; Edgar M; Pawel BR; Olshen A; Barr FG; Ladanyi M
J Pathol; 2007 Jun; 212(2):143-51. PubMed ID: 17471488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]